Table 1.
Patient Baseline Characteristics and Preoperative Parameters
| Pad at 3 months (n=91) | No pad at 3 months (n=361) | Total (n=452) | P value | ||
|---|---|---|---|---|---|
| Age (years) | 61.1±7.4 | 59.1±6.5 | 59.5±6.7 | 0.013a | |
| BMI (kg/m2) | 29.1±4.6 | 28.2±4.3 | 28.4±4.4 | 0.097a | |
| Race | White | 83 (91.2%) | 321 (88.9%) | 404 (89.4%) | 0.447b |
| African-American | 6 (6.6%) | 30 (8.3%) | 36 (8.0%) | ||
| Asian | 2 (2.2%) | 10 (2.8%) | 12 (2.6%) | ||
| Preoperative clinical stage | T1 | 68 (74.7%) | 309 (82.8%) | 377 (81.2%) | 0.028b |
| T2 | 19 (20.9%) | 48 (16.1%) | 67 (17.0%) | ||
| T3 | 4 (4.4%) | 4 (1.1%) | 8 (1.7%) | ||
| Gleason score of biopsy | ≤7 | 65 (71.1%) | 281 (77.8%) | 345 (0.9%) | 0.178b |
| ≥8 | 26 (28.9%) | 80 (22.2%) | 106 (13.5%) | ||
| Preoperative PSA (ng/mL) | 7.0±4.1 | 6.2±5.0 | 6.4±4.9 | 0.179a | |
| AUASS | 10.6±7.0 | 9.0±7.2 | 9.3±7.2 | 0.049a | |
| SHIM | 15.1±8.5 | 18.0±7.1 | 17.4±7.5 | 0.001a |
a
Independent sample t test; bchi-square test.
BMI=body mass index; PSA=prostate specific antigen; AUASS American Urological Association Symptom Score; SHIM=Sexual Health Inventory for Men.